S. Bettelli

发表

Clinical and molecular predictors of long-term response in HER2 positive metastatic breast cancer patients

C. Omarini, S. Bettelli, C. Caprera, 2018, Cancer biology & therapy.

Quick assessment of cell-free DNA in seminal fluid and fragment size for early non-invasive prostate cancer diagnosis.

A. Ciarrocchi, S. Bettelli, S. Kaleci, 2019, Clinica chimica acta; international journal of clinical chemistry.

Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management.

M. Dieci, S. Bettelli, A. Maiorana, 2008, The oncologist.

High-Resolution Melting Is a Sensitive, Cost-Effective, Time-Saving Technique for BRAF V600E Detection in Thyroid FNAB Washing Liquid: A Prospective Cohort Study

S. Bettelli, A. Maiorana, D. Santi, 2015, European Thyroid Journal.

254OACTIVITY OF NEOADJUVANT LAPATINIB (L) PLUS TRASTUZUMAB (T) FOR EARLY BREAST CANCER (EBC) ACCORDING TO PIK3CA MUTATIONS: PATHOLOGICAL COMPLETE RESPONSE (PCR) RATE IN THE CHERLOB STUDY AND POOLED ANALYSIS OF RANDOMIZED TRIALS.

M. Dieci, G. Tortora, S. Bettelli, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Multicenter Observational Study on Metastatic Non-Small Cell Lung Cancer Harboring BRAF Mutations: Focus on Clinical Characteristics and Treatment Outcome of V600E and Non-V600E Subgroups

M. Tiseo, A. Altimari, A. Zangrandi, 2022, Cancers.

Epidermal growth factor receptor gene copy number, K-ras mutation and pathological response to preoperative cetuximab, 5-FU and radiation therapy in locally advanced rectal cancer.

S. Bettelli, A. Maiorana, P. Conte, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

EGFR Polysomy in Squamous Cell Carcinoma of the Thyroid. Report of Two Cases and Review of the Literature

S. Bettelli, G. Zanelli, L. Schirosi, 2010, Tumori.

Double-blind, placebo-controlled, multicenter, randomized, phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative, operable breast cancer.

L. Cavanna, C. Boni, D. Generali, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Modulation of Mutational Landscape in HER2-Positive Breast Cancer after Neoadjuvant Chemotherapy

C. Omarini, S. Bettelli, S. Manfredini, 2020, Translational oncology.

Detection of human papillomavirus DNA in urinary bladder carcinoma by in situ hybridisation.

S. Bettelli, M. Migaldi, G. Trentini, 1999, Journal of clinical pathology.

Loss of HER2 positivity and prognosis after neoadjuvant therapy in HER2-positive breast cancer patients.

M. Dieci, C. Omarini, S. Bettelli, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Primary cutaneous mantle cell lymphoma of the leg with blastoid morphology and aberrant immunophenotype: a diagnostic challenge.

A. Cesinaro, S. Bettelli, L. Macciò, 2014, The American Journal of dermatopathology.

Therapeutic Outcomes and Clinical Features of Advanced Non-Small Cell Lung Cancer Carrying KRAS Mutations: A Multicenter Real-life Retrospective Study.

M. Tiseo, A. Altimari, A. Zangrandi, 2022, Clinical lung cancer.

Overall survival in patients with lung adenocarcinoma harboring “niche” mutations: an observational study

S. Bettelli, S. Manfredini, A. Maiorana, 2020, Oncotarget.

CtDNA-guided rechallenge with anti-EGFR therapy in RASwt metastatic colorectal cancer: Evidence from clinical practice

S. Bettelli, S. Manfredini, M. Dominici, 2022, Tumori.

PD05-01: Trans-CHER-Lob: A Biomarker Analysis of the Randomized Phase II Study of Neoadjuvant Chemotherapy Plus Trastuzumab, Lapatinib or Combined Trastuzumab and Lapatinib in HER2 Positive Operable Breast Cancer.

D. Amadori, A. Musolino, L. Cavanna, 2011 .

Expression of estrogen receptor in hemangioma of the uterine cervix: reports of three cases and review of the literature

S. Bettelli, F. Rivasi, L. Reggiani Bonetti, 2009, Archives of Gynecology and Obstetrics.

Prospective Biomarker Analysis of the Randomized CHER-LOB Study Evaluating the Dual Anti-HER2 Treatment With Trastuzumab and Lapatinib Plus Chemotherapy as Neoadjuvant Therapy for HER2-Positive Breast Cancer.

S. Bicciato, A. Musolino, M. Dieci, 2015, The oncologist.

Atypical Spitzoid melanocytic tumors: a morphological, mutational, and FISH analysis.

V. de Giorgi, D. Massi, A. Cesinaro, 2011, Journal of the American Academy of Dermatology.

BRAF mutations in sarcomatoid and large cell carcinoma of the lung.

P. Graziano, L. Muscarella, S. Bettelli, 2017, Human pathology.

Comparison of FDG whole-body PET / CT and gadolinium-enhanced whole-body MRI for distant malignancies in patients with malignant tumors : a meta-analysis

M. Dieci, S. Bettelli, P. Conte, 2012 .

Deepening the Knowledge of ROS1 Rearrangements in Non-Small Cell Lung Cancer: Diagnosis, Treatment, Resistance and Concomitant Alterations

S. Bettelli, S. Manfredini, G. Guaitoli, 2021, International journal of molecular sciences.

Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single-institution analysis.

M. Dieci, S. Bettelli, P. Conte, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Detection of Human Papillomavirus in Extragenital Bowen's Disease Using in Situ Hybridization and Polymerase Chain Reaction

A. Cesinaro, G. Collina, S. Bettelli, 1995, The American Journal of dermatopathology.

Does HPV play a role in the etiopathogenesis of ameloblastoma? An immunohistochemical, in situ hybridization and polymerase chain reaction study of 18 cases using laser capture microdissection

G. Rossi, S. Bettelli, M. Migaldi, 2005, Modern Pathology.

Alterations of 9p21 analysed by FISH and MLPA distinguish atypical spitzoid melanocytic tumours from conventional Spitz’s nevi but do not predict their biological behaviour

A. Cesinaro, S. Bettelli, M. Migaldi, 2010, Histopathology.

Alveolar rhabdomyosarcoma of the uterine cervix. A case report confirmed by FKHR break-apart rearrangement using a fluorescence in situ hybridization probe on paraffin-embedded tissues.

S. Bettelli, F. Rivasi, L. Botticelli, 2008, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Analysis of KRAS, NRAS, PIK3CA, and BRAF mutational profile in poorly differentiated clusters of KRAS-mutated colon cancer.

S. Bettelli, C. Caprera, S. Manfredini, 2017, Human pathology.

FISH analysis in cell touch preparations and cytological specimens from formalin‐fixed fetal autopsies

S. Bettelli, F. Rivasi, L. Schirosi, 2008, Diagnostic cytopathology.

Prediction of distant recurrence in resected stage I and II lung adenocarcinoma.

J. Lanchbury, S. Bettelli, A. Maiorana, 2016, Lung cancer.

Synchronous occurrence of squamous-cell carcinoma "transformation" and EGFR exon 20 S768I mutation as a novel mechanism of resistance in EGFR-mutated lung adenocarcinoma.

G. Rossi, S. Bettelli, S. Manfredini, 2017, Lung cancer.

Poorly differentiated clusters (PDC) in colorectal cancer: what is and ought to be known

S. Bettelli, L. Reggiani Bonetti, C. Palmiere, 2016, Diagnostic Pathology.

Prognostic role of EGFR gene copy number and KRAS mutation in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy

S. Bettelli, P. Conte, G. Luppi, 2010, British Journal of Cancer.

Cytomegalovirus infection of the upper gastrointestinal tract: a clinical and pathological study of 30 cases

S. Bettelli, L. Reggiani Bonetti, L. Losi, 2011, Scandinavian journal of gastroenterology.

Detection of EGFR-Activating and T790M Mutations Using Liquid Biopsy in Patients With EGFR-Mutated Non-Small-Cell Lung Cancer Whose Disease Has Progressed During Treatment With First- and Second-Generation Tyrosine Kinase Inhibitors: A Multicenter Real-Life Retrospective Study.

M. Fiorentino, M. Tiseo, A. Altimari, 2020, Clinical lung cancer.

Unexpected tumor response to palliative pelvic radiotherapy in mismatch repair-deficient advanced prostate cancer: a case report

F. Lohr, S. Bettelli, E. Mazzeo, 2020, Journal of Medical Case Reports.

(Not-so) Unexpected Tumor Response to Palliative Pelvic Radiotherapy in Mismatch Repair-Deficient Advanced Prostate Cancer

F. Lohr, S. Bettelli, E. Mazzeo, 2020 .

ROS1 pattern of immunostaining in 11 cases of spitzoid tumour: comparison with histopathological, fluorescence in‐situ hybridisation and next‐generation sequencing analysis

A. Cesinaro, S. Bettelli, S. Manfredini, 2021 .

Cerebrospinal fluid cytology in a case of primary diffuse leptomeningeal and pineal melanocytic lesion, with histological confirmation.

S. Bettelli, F. Bertolini, L. Reggiani-Bonetti, 2010, Pathology.

Cell of origin (COO), BCL2/MYC status and IPI define a group of patients with Diffuse Large B-cell Lymphoma (DLBCL) with poor prognosis in a real-world clinical setting.

S. Sacchi, S. Bettelli, A. Maiorana, 2021, Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis.

KRAS, NRAS, BRAF mutations and high counts of poorly differentiated clusters of neoplastic cells in colorectal cancer: observational analysis of 175 cases

S. Bettelli, V. Barresi, L. R. Bonetti, 2015, Pathology.

Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysis

M. Dieci, C. Omarini, S. Bettelli, 2012, Journal of Clinical Pathology.

Differential molecular pathways expression in HER2 positive early breast cancer according to hormone receptor status

C. Omarini, S. Bettelli, C. Caprera, 2019, Journal of Cancer Research and Clinical Oncology.

Durable remission in a patient with leptomeningeal relapse of a MYC/BCL6‐positive double‐hit DLBCL treated with lenalidomide monotherapy

S. Bettelli, A. Maiorana, M. Salati, 2017, Hematological oncology.

Beyond the Beyond: A Case of an Extraordinary Response to Multiple Lines of Therapy in a de novo Metastatic HER2-Negative Gastric Cancer Patient

S. Bettelli, S. Cascinu, L. Reggiani Bonetti, 2018, Gastrointestinal Tumors.

Microsatellite and EGFR, HER2 and K-RAS Analyses in Sclerosing Hemangioma of the Lung

G. Rossi, S. Bettelli, A. Cavazza, 2007, The American journal of surgical pathology.

Surrogate Molecular Classification of Invasive Breast Carcinoma: A Comparison Between Core Needle Biopsy and Surgical Excision, With and Without Neoadjuvant Therapy

S. Bettelli, A. Ambrosini-Spaltro, G. Ficarra, 2019, Applied immunohistochemistry & molecular morphology : AIMM.

Histopathological variables in liver metastases of patients with stage IV colorectal cancer: potential prognostic relevance of poorly differentiated clusters.

S. Bettelli, L. Reggiani Bonetti, F. Gelsomino, 2018, Human pathology.

The prognostic role of c-kit protein expression in resected large cell neuroendocrine carcinoma of the lung.

G. Rossi, S. Bettelli, M. Migaldi, 2004, The Annals of thoracic surgery.

Mutational Profile of Metastatic Breast Cancer Tissue in Patients Treated with Exemestane Plus Everolimus

C. Omarini, S. Bettelli, C. Caprera, 2018, BioMed research international.

Assessment of freezing effects and diagnostic potential of BioBank healthy and neoplastic breast tissues through HR-MAS NMR spectroscopy

S. Bettelli, A. Maiorana, E. Libertini, 2015, Metabolomics.

EGFR gene copy number, KRAS and BRAF status, PTEN and AKT expression analysis in patients with metastatic colon cancer treated with anti-EGFR monoclonal antibodies ± chemotherapy.

S. Bettelli, P. Conte, G. Luppi, 2009, Journal of Clinical Oncology.

Clinico-Pathological, Cytogenetic and Molecular Profiles of Primary Cutaneous Diffuse Large B-Cell Lymphomas.

S. Sacchi, L. Braglia, S. Bettelli, 2023, Human pathology.

Clinical Impact and Prognostic Role of KRAS/BRAF/PIK3CA Mutations in Stage I Colorectal Cancer

S. Bettelli, C. Caprera, S. Manfredini, 2018, Disease markers.

Predictive value of EGFR gene copy number and K-ras mutation for pathological response to preoperative cetuximab, 5FU, and radiation therapy in locally advanced rectal cancer (LARC)

S. Bettelli, P. Conte, F. Bertolini, 2008 .

neuroendocrine carcinoma of the lung The prognostic role of c-kit protein expression in resected large cell

G. Rossi, S. Bettelli, M. Migaldi, 2013 .